Your browser doesn't support javascript.
loading
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Jung, Christoph; Kmiec, Dorota; Koepke, Lennart; Zech, Fabian; Jacob, Timo; Sparrer, Konstantin M J; Kirchhoff, Frank.
Afiliação
  • Jung C; Institute of Electrochemistry, Ulm University, Ulm, Germany.
  • Kmiec D; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
  • Koepke L; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
  • Zech F; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
  • Jacob T; Institute of Electrochemistry, Ulm University, Ulm, Germany.
  • Sparrer KMJ; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
  • Kirchhoff F; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
J Virol ; 96(6): e0207721, 2022 03 23.
Article em En | MEDLINE | ID: mdl-35225672
ABSTRACT
Emerging strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, that show increased transmission fitness and/or immune evasion are classified as "variants of concern" (VOCs). Recently, a SARS-CoV-2 variant first identified in November 2021 in South Africa has been recognized as a fifth VOC, termed "Omicron." What makes this VOC so alarming is the high number of changes, especially in the viral Spike protein, and accumulating evidence for increased transmission efficiency and escape from neutralizing antibodies. In an amazingly short time, the Omicron VOC has outcompeted the previously dominating Delta VOC. However, it seems that the Omicron VOC is overall less pathogenic than other SARS-CoV-2 VOCs. Here, we provide an overview of the mutations in the Omicron genome and the resulting changes in viral proteins compared to other SARS-CoV-2 strains and discuss their potential functional consequences.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2022 Tipo de documento: Article